Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis.
Fiche du document
- doi: 10.1002/rth2.12376
- issn: 2475-0379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1002/rth2.12376
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32685893
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2475-0379
Ce document est lié à :
info:eu-repo/grantAgreement/SNF/Careers/PZ00P3-185927///
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_F213C2D7C2EC1
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Ultrasonography Sonography Echography Imaging, UltrasonicCiter ce document
A. Longchamp et al., « Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis. », Serveur académique Lausannois, ID : 10.1002/rth2.12376
Métriques
Partage / Export
Résumé
The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and coronavirus disease 2019 (COVID-19), has caused more than 3.9 million cases worldwide. Currently, there is great interest to assess venous thrombosis prevalence, diagnosis, prevention, and management in patients with COVID-19. To determine the prevalence of venous thromboembolism (VTE) in critically ill patients with COVID-19, using lower limbs venous ultrasonography screening. Beginning March 8, we enrolled 25 patients who were admitted to the intensive care unit (ICU) with confirmed SARS-CoV-2 infections. The presence of lower extremity deep vein thrombosis (DVT) was systematically assessed by ultrasonography between day 5 and 10 after admission. The data reported here are those available up to May 9, 2020. The mean (± standard deviation) age of the patients was 68 ± 11 years, and 64% were men. No patients had a history of VTE. During the ICU stay, 8 patients (32%) had a VTE; 6 (24%) a proximal DVT, and 5 (20%) a pulmonary embolism. The rate of symptomatic VTE was 24%, while 8% of patients had screen-detected DVT. Only those patients with a documented VTE received a therapeutic anticoagulant regimen. As of May 9, 2020, 5 patients had died (20%), 2 remained in the ICU (8%), and 18 were discharged (72%). In critically ill patients with SARS-CoV-2 infections, DVT screening at days 5-10 of admission yielded a 32% prevalence of VTE. Seventy-five percent of events occurred before screening. Earlier screening might be effective in optimizing care in ICU patients with COVID-19.